One of our aims is to help provide treatment or trial opportunities to those children who have exhausted current treatment pathways and have no further options. While wishing to bring new and exciting trials to the clinic, originating in the UK or abroad, we encourage trials that have a low toxicity.
SKC’s aims overlap in many areas with the American charity Solving Kids’ Cancer who have kindly allowed us to use their international scientific advisory board for assessing UK based research proposals. Alongside British neuroblastoma charity J-A-C-K and SKC is a founding member of International Neuroblastoma Research Collaboration for Effective Delivery (INBRACED) which aims to collaborate with research foundations around the world to bring the best and latest treatments and trials to children everywhere.
We believe that through this collaborative we will enable more children to access the very best trials without delay, regardless of geographical location. The increased international collaboration generated by this initiative will be of benefit to researchers, clinicians and families worldwide.